Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations and applications ranging from media development to process optimization
Roots Analysis has announced the addition of “Mini Bioreactors and Micro Bioreactors Market, 2022-2035” report to its list of offerings.
Minibioreactors and microbioreactors enable faster experimental throughput at relatively lower costs and allow bioprocessing of samples, thereby reducing the downtime and increasing the number of batches produced in a given period of time. Moreover, stakeholders in this domain are also focused on incorporating a variety of features for monitoring of different control parameters, such as CO2 levels, dissolved oxygen, pH and temperature ranges, in order to analyze and determine essential conditions of the culture environment and optimize the overall performance..
Key Market Insights
Currently, over 60 mini bioreactors and micro bioreactors are available in the market
Majority (55%) of these equipment are single-use bioreactors, followed by reusable bioreactors, which constitute around 24% of the total number of mini bioreactors and micro bioreactors available in the market.
Get Detailed Report: https://www.rootsanalysis.com/reports/mini-bioreactors-market.html
More than 25 companies are engaged in the development of mini bioreactors and micro bioreactors
The current market landscape features the presence of both well-established players and new entrants; however, more than 70% of the players are small and mid-sized companies. Further, majority (more than 57%) of the developers are headquartered in Europe, followed by North America (25%) and Asia-Pacific (18%).
More than 250 patents related to mini bioreactors and micro bioreactors, were filed since 2016
Of these, over 70% were patent applications, while around 28% were granted patents. Of the total granted patents, close to 42% were filed in North America, followed by WIPO (36%), Europe (14%) and Asia-Pacific (8%).
North America is anticipated to capture over 35% of the global market share in 2035
Mini bioreactors and micro bioreactors developed for batch / fed-batch operations are likely to capture the highest market share (90%). Further, in terms of revenues generated from the product sales, North America is likely to capture the maximum share in the global market, followed by Europe (31%) and Asia Pacific (22%).
Request for Customization @ https://www.rootsanalysis.com/reports/mini-bioreactors-market/request-customization.html
The financial opportunity within the minibioreactors and microbioreactors market has been analyzed across the following segments:
Type of Cell Culture
- Mammalian Culture
- Microbial Culture
- Viral Culture
- Insect Culture
- Other Cell Culture
Mode of Operation
- Batch / Fed-Batch reactors
- Continuous reactors
- Biopharmaceutical / Pharmaceutical Industries
- Academic / Research Institutes
- North America
- Asia Pacific
- Rest of the World
The research includes detailed profiles of key players (listed below) engaged in the development of mini bioreactors and micro bioreactors; each profile features an overview of company, details on, mini bioreactors and micro bioreactors product portfolio, recent developments, and an informed future outlook
- Merck Millipore
- Pall Corporation
Read Our Latest Blogs:
Visit for More Insights: https://www.rootsanalysis.com/reports.html
Read Our Latest Press Release: https://www.rootsanalysis.com/press-releases.html
Latest Blogs On Healthcare Industry: https://www.rootsanalysis.com/blog/
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Roots Analysis Private Limited
+1 (415) 800 3415
+44 (122) 391 1091